53. Studies for Effects on Fertility and Early Embryonic Development to Implantation of Qingling-Sibutramine hydrochloride in Mice
万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

53. Studies for Effects on Fertility and Early Embryonic Development to Implantation of Qingling-Sibutramine hydrochloride in Mice

引用
To better understand the safety property to reproductive and development in human of Qingling-Sibutramine hydrochloride (Ql-Sibutramine), a study of toxic effects/disturbances resulting from treatment from before mating (males/females) through mating and implantation of Ql-Sibutramine in mice were conduc-ted. Ql-Sibutramine was administrated in drink water. A premating treatment interval of 8 weeks for male and 2 weeks for female were done in mice. Treatment was continued throughout mating to termination of males and through implantation for female. The dosages were 32 mg*kg-1*d-1 (1/5 LD50), 2.83 mg*kg-1*d-1, 0.25 mg*kg-1*d-1, and a control group. Assessment of maturation of gametes, mating behavior, fertility, preimplantation stages of the embryo, implantation and toxicity to the parent mice were done. The boby weight lose was observed in the group of 32 mg*kg-1*d-1 in male mice. No other toxic effects in the parent mice and offspring were observed.

Qingling-Sibutramine hydrochloric (Ql-Sibutramine)、Fertility、Early Embryonic Development

13

R73(肿瘤学)

2004-03-26(万方平台首次上网日期,不代表论文的发表时间)

共1页

240

相关文献
评论
暂无封面信息
查看本期封面目录

癌变.畸变.突变

1004-616X

44-1063/R

13

2001,13(4)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn